REF Contribution Table 2006 Implicit Price January 2006 Risk Equalisation Fund.

Slides:

Advertisements

Similar presentations

Chronic Disease Prevention and Management Why is this focus area important? Chronic disease such as heart disease, stroke, cancer, diabetes and arthritis.

Advertisements

Chapter 4: Hospitalization 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.

Environmental exposures  Cancer risks:  Tobacco smoke  Radon in homes  Arsenic.

HIV/AIDS In The United States J.AD.DA.S. Table of Contents Epidemiology AIDS in the United States AIDS by ethnicity AIDS by exposure category AIDS deaths.

BRFSS Salt Intake Module Epidemiology and Surveillance Team Epidemiology and Surveillance Branch Division for Heart Disease and Stroke Prevention National.

Key messages Stephen S Lim, et al. Lancet 2007; 370:

A Profile of Chronic Disease in Nevada Tracey Green, MD Nevada State Health Officer January Shaping a Healthy Nevada: Making a Difference in.

Compiled by: Riverside County Community Health Agency

Valuation issues Jan Sørensen, Health Economist CAST – Centre for Applied Health Services Research and Technology Assessment University of Southern Denmark.

1 times table 2 times table 3 times table 4 times table 5 times table

Chapter 3: Morbidity & Mortality 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.

Healthy Living Factors in Preventing Serious Disease ( Diabetes, Cancer Heart Attack, Stroke)

Healthcare Cover with Lifestage Modelling The Impact of Best Advice on the Medical Schemes Industry Anthea Towert Technical and Actuarial Consulting Solutions.

Multiplication Table Grid

San Francisco HIV Health Services Persons 65 & Older Living with HIV/AIDS in San Francisco: An Introduction Prepared by Robert Whirry, Program Development.

Research and analysis by Avalere Health Are Medicare Patients Getting Sicker? December 2012.

Lecture 3: Measuring the Occurrence of Disease

Centre for Actuarial Research The Costing of Prescribed Minimum Benefits January 2003.

Centre for Actuarial Research The Costing of the Chronic Disease List January 2003.

Prevalence of Chronic Disease & Comorbid Conditions in the CHAIN Cohort CHAIN Report Peter Messeri, Gunjeong Lee, Sara Berk Mailman School of Public.

NATIVE ELDER CAREGIVER CURRICULUM NECC Caring for Our Elders: Health Disparities Among Native Elders 2.2 Caring for our Elders: Health Disparities Among.

Estimating the Burden of Serious Fungal Diseases in Thailand Methee Chayakulkeeree 1, David W. Denning 2* 1 Division of Infectious Diseases and Tropical.

University of Leeds, March 2008 Domenica Rasulo (User Fellow)

Epidemiology With Respect to the Dynamics of Infectious Diseases Huaizhi Chen.

Centre for Actuarial Research The Impact of PMBs on Affordability January 2003.

Quarterly HIV/AIDS Analysis for Michigan January 1, 2008 Michigan Department of Community Health HIV/STD/Viral Hepatitis and TB Epidemiology Section Division.

Latest in Health Law…. SAPRAA June Key pieces of legislation Health Charter & BB BEE Medicines & Related Substance Act, regulations & Code Medical.

Measures of Disease Frequency COURTNEY D. LYNCH, PhD MPH ASSISTANT PROFESSOR DEPT. OF OBSTETRICS & GYNECOLOGY

OBJECTIVEMETHODSRESULTS BURDEN OF SERIOUS FUNGAL INFECTIONS IN SERBIA Valentina Arsic Arsenijevic 1, Sandra Sipetic Grujicic 2, Marina Pekmezovic 1, David.

Aortic Stenosis -The Unmet Need Simon Ray University Hospitals of South Manchester ACI 2009.

Nowossadeck, E Population Aging and Hospitalization for Chronic Disease in Germany Dtsch Arztebl Int 2012; 109(9): 151-7; DOI: /arztebl

SOCIAL HEALTH INSURANCE POLICY Presentation to Health Portfolio Committee 7 June 2005.

Health Outcomes due to Alcohol 14 July 2005 Kanitta Bundhamcharoen MOPH.

October Warsaw1 Price Volume Agreements in Hungary National Health Insurance Fund Administration (OEP) Pharmaceutical Department Tamás Kovacs.

2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

 Ischaemic heart disease reduces blood supply to the heart muscles and is one of the major cardiovascular diseases.

Multiplication Table Grid

Tables Learning Support

at risk) for Medicare patients aged 66 and older, by CKD status, 2013

The Age of Sustainable Development

HOW ARE PRIORITY ISSUES FOR AUSTRALIA’S HEALTH IDENTIFIED? HEALTH PRIORITIES IN AUSTRALIA.

Centre for Actuarial Research Prescribed Minimum Benefits Package.

Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.

CDL Disease Prevalence: Diagnosis and Treated 8 June 2009 Additional material supplied with IMSA NHI Policy Brief 3 National Health Insurance Policy Brief.

Epidemiological measureas. How do we determine disease frequency for a population?

LIMS Reforms and Equitable Subsidies 20 January 2010 National Health Insurance Policy Brief 17.

Universal Coverage and Equitable Subsidies 18 January 2011 National Health Insurance Policy Brief 16.

Estimating serious fungal disease burden in the Philippines

The Impact of Chronic Disease on a Future NHI

US Burden of Disease and Injury Study, 1996

The Costing of the Chronic Disease List

Ratio of percentile groups

The Costing of Prescribed Minimum Benefits

Bronx Profile Line represents the proportion of NYS population living in Bronx. * The Center for Health Workforce Studies - U. of Albany; School of Public.

The Impact of Chronic Disease on a Future NHI

Chapter 6: CKD among Children and Adolescents

2016 Annual Data Report, Vol 1, CKD, Ch 3

מדינת ישראל הוועדה לאנרגיה אטומית

Nat. Rev. Cardiol. doi: /nrcardio

Key messages Dele O Abegunde, et al. Lancet 2007; 370:

High Chronic Disease Burden Among U.S. Women

CIRCULAR 8 OF 2006 WILLEM CLAASEN 9 MARCH 2006.

Prescribed Minimum Benefits Package

3 times tables.

6 times tables.

Reducing Fragmented Risk Pools

Incidence Incidence of a disease is: “the rate at which new cases occur in a population in a given period, usually in the past 12 months (one calendar.

Presentation transcript:

REF Contribution Table 2006 Implicit Price January 2006 Risk Equalisation Fund

Methodology  Derived using:  REF Contribution Table 2006 – this is effectively a table of average cost  Assumed REF Grid Count – this effectively gives the prevalence  Price = Average Cost x Prevalence  Note we are not strictly using prevalence in its epidemiological meaning when using the REF Grid Count

Risk Equalisation Fund Prevalence of Chronic Disease Source: REF Contribution Table 2006 Risk Equalisation Fund

Prevalence by Age of Chronic Disease Source: REF Contribution Table 2006

Risk Equalisation Fund Proportion of Prevalence by Age of Chronic Disease Source: REF Contribution Table 2006

Risk Equalisation Fund Price of Chronic Disease Source: REF Contribution Table 2006

Risk Equalisation Fund Price by Age of Chronic Disease Source: REF Contribution Table 2006

Risk Equalisation Fund Price by Age of Chronic Disease Source: REF Contribution Table 2006

Risk Equalisation Fund Price by Age of Chronic Disease Using HIV/AIDS Prevalence in 2010 Source: REF Contribution Table 2006

Risk Equalisation Fund Price by Age of Chronic Disease The burden of heart disease is clear. Source: REF Contribution Table 2006

Risk Equalisation Fund Components of Price of PMBs Source: REF Contribution Table 2006

Risk Equalisation Fund Proportion of Price by Age Source: REF Contribution Table 2006

Risk Equalisation Fund Proportion of Price by Age 2010 Source: REF Contribution Table 2006

Risk Equalisation Fund DTP and CDL as Proportion of PMB Source: REF Contribution Table 2006

Risk Equalisation Fund Provider Category as Proportion of PMB Margins could become part of Hospital or Medicine Source: REF Contribution Table 2006